NHC NATIONAL HEALTHCARE CORP Insider Trading

Director Emil E Hassan sold 5,937 shares of NHC at $200.00 for $1,187,400; stock near 52-week high ($205.90), down -3.7% from peak.

Emil E Hassan (Director) divested 5,937 shares representing 8.3% of his pre-transaction holdings, executing the sale at $200.00 per share when NHC traded near its 52-week high of $205.90. The stock has appreciated 22.8% over the past 90 days and currently sits -3.7% below its 52-week peak, positioning this sale in a period of strong price momentum. Reviewing his same-ticker history at NHC, a prior sell on 2025-11-25 posted a +13.4% return over 90 days post-transaction, indicating the previous sale was poorly timed relative to subsequent upward movement. The company exhibits solid fundamentals with 16.1% annual revenue growth, $35.9M net income on $381.8M quarterly revenue, and a P/E of 25.04.

Director Lisa Piercey initiates stake in NHC: 949 shares at $184.26 (post-transaction: 949 shares)

Lisa Piercey, a Director, purchased 949 shares of National Healthcare Corp on June 1, 2026, at $184.26 per share for a total value of $174,858.85, establishing an initial shareholding position. The transaction occurs with NHC trading at $183.35 currently, near its 52-week midpoint after a +4.9% gain over 30 days and +6.1% over 90 days, while the stock remains -10.6% from its 52-week high of $205.06. The company displays solid fundamentals: latest quarterly revenue of $381,821,000.00 with net income of $35,857,000.00, annual growth of +16.1%, and a reasonable P/E of 23.15 on a market cap of $2,863,861,177.35. A director's initiation of a new shareholding position warrants attention, though the significance is moderated by the relatively modest dollar amount and absence of prior trading history context at this ticker.

Director Richard F Jr Laroche sold 7,500 NHC shares at $195.14 on 2026-05-21 for $1,463,565.75; retained 205,760 shares post-sale.

Richard F Jr Laroche, a director at National Healthcare Corp, sold 7,500 shares (3.5% of his pre-transaction holdings) at $195.14, reducing his stake to 205,760 shares. The sale occurred near the 52-week high of $205.06, with the stock currently trading at $195.41, down 4.7% from that peak. While his cross-ticker track record shows only 1 prior buy with no timing data yet available, his same-ticker history at NHC shows one prior purchase on 2023-06-29 whose outcome remains unmeasurable. The modest position reduction occurs within the context of the company's strong fundamentals—annual revenue growth of 16.1% and a market cap of $3.1B—though the company trades at a P/E of 24.67.

Director Hassan Emil E sold 7,500 NHC shares at $138.52; retains 65,595 shares post-transaction.

Hassan Emil E (Director) sold 7,500 shares of National Healthcare Corp at $138.52 on 2025-11-25, reducing his holdings by 10.3% to 65,595 shares. The transaction was executed at a price $1.43 above the current market price of $137.18, with the stock having appreciated 14.0% over 30 days and 21.2% over 90 days from the transaction date. The underlying business shows strong fundamentals: annual revenue growth of 14.5%, net income of $39,239,000.00 on revenue of $382,661,000.00, and a P/E of 21.01. While the sale is measurable and reduces a significant director holding, the limited scale of the reduction (10.3%) and the company's solid financial trajectory provide context for the activity.

Insider at National Healthcare Corp (NHC) sold 25,729 shares for $2,774,857.21 on 2024-12-31; stock down -22.1% from 52-week high

An insider at National Healthcare Corp sold 25,729 shares at $107.85 on 2024-12-31, reducing holdings by 2.4% to 1,030,887 shares. The stock has declined -22.1% from its 52-week high of $137.13 and is currently trading at $106.80, down -15.9% over the past 30 days. Fundamentals remain solid with P/E of 13.27, annual revenue growth of 5.1%, and net income of $42,789,000.00, suggesting the decline is driven by sentiment rather than deterioration in operations. The insider's cross-ticker track record shows only 1 prior sell, and same-ticker history shows a recent sale on 2024-12-20, though outcome measurement is not yet available for either trade.

National Health Corp sells 28,147 shares of NHC at $113.71; holds 1,056,616 shares post-sale amid 18.5% decline from 52-week high.

An insider at National Health Corp sold 28,147 shares for $3.2M, reducing holdings by 2.6% to 1,056,616 shares remaining. The sale occurred at $113.71, while the stock currently trades at $111.76—a 1.7% decline from the transaction price—and stands 18.5% below its 52-week high of $137.13. The company's fundamentals remain solid with quarterly revenue of $340.2M, net income of $42.8M, and a P/E of 13.88, though the stock has declined 11.4% over the past 30 days and 9.9% over 90 days. The transaction represents a moderate reduction in a substantial insider position but does not constitute a complete exit; the lack of a broader selling pattern or disclosed motivation limits the signal clarity for investors interpreting this single transaction.